Laura King
Founder and CEO
1 Podcast on BackTable
Laura King is the founder and CEO of Elucent Medical, and the former president and CEO of NeuWave Medical.
Learn from the experiences and expertise of Laura King and other leading voices in your specialty on the BackTable app.
Episode # 25 • 29 Apr 2022
Next Level Stuff, the Exit: Part III of the Neuwave Story
To close our BackTable Innovation series on NeuWave, we invited Laura King and Dr. Fred Lee to speak about growing their medical device company through various stages, from Series A funding to acquisition by Johnson & Johnson.
More from Laura King
About
After graduating from the University of California, Davis with an economics degree, Laura King got a job in finance at General Electric (GE). She rose quickly through the ranks, and after a series of high-level jobs she was promoted to run GE Healthcare’s $1.2 billion interventional cardiology and surgery business. She also became an officer of the corporation. It was there at the top that King began to question whether there was a better way to satisfy her passion for clinical innovation.
King started thinking she might prefer running a mid-sized, private equity-backed company, but the startup world intervened. Madison-based Venture Investors hired her to analyze a young company called NeuWave Medical, which King learned had great technology and no revenue. King decided to take a big risk and became NeuWave’s founding CEO. She grew it from nothing through a successful sale to Ethicon, a subsidiary of Johnson & Johnson. King now heads Elucent Medical, which she co-founded with her NeuWave partners.
The Materials available on BackTable are provided for informational and educational purposes only and are not a substitute for the independent professional judgment of a qualified healthcare professional in diagnosing or treating patients. Any opinions, statements, or views expressed are those of the individual contributors and do not necessarily reflect those of the publisher, platform, or any affiliated organization.